Spectral Ultrasound Combined With Clinical Pathological Parameters in Prediction of Axillary Lymph Node Metastasis in Breast Cancer
Journal of Ultrasound in Medicine · 2024
DOI: 10.1002/jum.16564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2024. Verfasst von Pengfei Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphatic Metastasis, Axilla, Lymph Nodes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Capital's Funds for Health Improvement and Research, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To explore the clinical value of the nomogram based on spectral Doppler ultrasound combined with clinical pathological parameter in predicting axillary lymph node metastasis in breast cancer.
Methods
We prospectively gathered clinicopathologic and ultrasonic data from 240 patients confirmed breast cancer. The risk factors of axillary lymph node metastasis were analyzed by univariate and multivariate logistic regression, and the prediction model was established. The model calibration, predictive ability, and diagnostic efficiency in the training set and the testing set were analyzed by receiver operating characteristic curve and calibration curve analysis, respectively.
Results
Univariate analysis showed that lymph node metastasis was related with tumor size, Ki‐67, axillary ultrasound, ultrasound spectral quantitative parameter, internal echo, and calcification ( P < .05). Multivariate logistic regression analysis showed that the Ki‐67, axillary ultrasound, quantitative parameter (the mean of the mid‐band fit in tumor and posterior tumor) were independent risk factors of axillary lymph node metastasis ( P < .05). The models developed using Ki‐67, axillary ultrasound, and quantitative parameters for predicting axillary lymph node metastasis demonstrated an area under the receiver operating characteristic curve of 0.83. Additionally, the prediction model exhibited outstanding predictability for axillary lymph node metastasis, as evidenced by a Harrell C‐index of 0.83 (95% confidence interval 0.73–0.93).
Conclusion
Axillary ultrasound combined with Ki‐67 and spectral ultrasound parameters has the potential to predict axillary lymph node metastasis in breast cancer, which is superior to axillary ultrasound alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing, China.
- Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China.
- Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Linxue Qian, Jianguo Ma, Xiangdong Hu
Förderung
- Capital's Funds for Health Improvement and Research
- National Natural Science Foundation of China
Zitieren
APA
Sun, P., Han, J., Li, M., Wang, Z., Guo, R., Zhang, Y., Qian, L., Ma, J., & Hu, X. (2024). Spectral Ultrasound Combined With Clinical Pathological Parameters in Prediction of Axillary Lymph Node Metastasis in Breast Cancer. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16564
Vancouver
Sun P, Han J, Li M, Wang Z, Guo R, Zhang Y, et al. Spectral Ultrasound Combined With Clinical Pathological Parameters in Prediction of Axillary Lymph Node Metastasis in Breast Cancer. Journal of Ultrasound in Medicine. 2024. doi:10.1002/jum.16564
BibTeX
@article{Sun2024,
author = {Sun, Pengfei and Han, Jiaqi and Li, Min and Wang, Zhixiang and Guo, Ruifang and Zhang, Yanning and Qian, Linxue and Ma, Jianguo and Hu, Xiangdong},
title = {Spectral Ultrasound Combined With Clinical Pathological Parameters in Prediction of Axillary Lymph Node Metastasis in Breast Cancer},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
doi = {10.1002/jum.16564}
}
EUVIMED